glp-1 market news november 2025 Receptor Agonist Size and Share GLP-1 Pipeline Update: November 2025

Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study

*Correspondence: Maria Paula Macedo, [email protected] This article was submitted to Molecular Medicine, a section of the journal Frontiers in Cell and Developmental Biology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Over time, these drops might reshape what is sold in stores

By identifying your genetic starting point before committing to a standard dose ladder, PlexusDx helps avoid weeks of preventable nausea and adjustments

Schedule Your Consultation Call 205-859-2136 to schedule your personalized consultation with Dr